Navigation Links
SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
Date:6/5/2008

the MHI fully supports the idea that HDL-based therapies are potentially the next frontier in the battle against cardiovascular disease".

"Apo AI(Milano) is a drug candidate with outstanding clinical and commercial potential," said Andrew Baum, president and chief executive officer of SemBioSys. "Manufacturing challenges have been a major impediment to drug development efforts. We have now shown that safflower Apo AI(Milano), which we believe can be produced in a cost effective manner, has the potential to allow for the full development and commercialization of this drug candidate. We expect that the data we have previously generated, together with the latest animal model data, will greatly facilitate and accelerate our partnership efforts for this program."

About Apo AI/Apo AI(Milano)

Apo AI is a naturally occurring human protein being developed as a cardiovascular therapy to stabilize and reverse atherosclerotic plaque deposition for the prevention and treatment of cardiovascular disease. Apo AI is believed by many clinicians to be the archetype for a new generation of cardiovascular drugs (HDL therapies). Apo AI is the major apolipoprotein associated with HDL, commonly referred to as "good cholesterol", which naturally removes plaque from arteries. Published studies have shown that Apo AI(Milano), which is a variant of Apo AI, in a phospholipid formulation could reduce plaque volume at a level and speed unattainable with any current drug therapy. If successfully commercialized, predicted high dosing (multiple grams per course of patient treatment) coupled with a large patient population would be expected to drive volume demand of several tons of Apo AI(Milano) per year, underscoring the value of a highly scalable, plant manufacturing solution. SemBioSys' proprietary safflower derived Apo AI(Milano) is a des I, 2 variant of Apo AI(Milano) as previously described in the literature.

About Cardiovascular Disease

Atherosclerotic card
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
2. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
3. SemBioSys announces first quarter 2008 financial and operational results
4. SemBioSys receives milestone payments from AVAC Ltd.
5. SemBioSys initiates toxicology study for safflower-produced insulin
6. SemBioSys announces 2007 financial and operational results
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
9. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
10. SemBioSys signs option agreement for safflower-produced food ingredient
11. SemBioSys announces 2007 third quarter results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 02, 2015 Shimadzu Scientific Instruments will ... on LCMS and marijuana analysis at the Pittcon 2015 ... to 12 at the Ernest N. Morial Convention Center ... by booth 3121 to discuss laboratory challenges with Shimadzu’s ... proven products help save time, money and effort in ...
(Date:3/2/2015)... 2, 2015 Analyzing a puzzling multisystem ... a new syndrome, shedding light on key biological ... important information to help caregivers manage the disorder, ... "This syndrome illuminates a very important ... switch that controls many other genes," said study ...
(Date:3/2/2015)... 2, 2015  Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics, today announced that it will ... Conference in Miami, FL at the Loews Miami Beach Hotel.  ... of Pfenex, will provide an overview of the ... am ET. A live audio webcast and archive ...
(Date:3/2/2015)... Calif. , March 2, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... financial and operating results on Tuesday, March 10, 2015 ... Company will host a conference call and webcast on ... 1:30 p.m. Pacific to discuss the results and recent ...
Breaking Biology Technology:Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 3New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 2New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 3New Genetic Syndrome Found, Arising from Errors in 'Master Switch' During Early Development 4Asterias Biotherapeutics to Report Fourth Quarter and Full Year 2014 Results on March 10, 2015 2
... are superior to synthetic HRT with greater cardiovascular ... Feb. 23 The most comprehensive analysis to ... leading peer-reviewed publication for practicing clinicians, showed that ... and are more efficacious than their synthetic counterparts. ...
... the Minimally Invasive Treatment of Bone Fractures Achieves ... R.I., Feb. 23 IlluminOss Medical Inc., a ... Bone Stabilization System for orthopedic surgery, today announced ... of Registration issued by BSI (British Standards Institute). ...
... YORK, Feb. 23 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... to release,fourth quarter and full year 2008 financial results ... The Company will hold a ... 2009 to,discuss fiscal fourth quarter and full year 2008 ...
Cached Biology Technology:New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 2New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy 3IlluminOss Medical Receives ISO 13485 Certification 2
(Date:1/22/2015)... Conn. , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: ... mobile commerce market, reports on the recent success of the Wocket™ smart ... Wocket smart wallet was named as one of the "11 ... the "5 Best Products Launched At CES So Far" by Newseveryday.com and ...
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) has ... Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, ... report to their offering. , ... be worn on the user,s body and have ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... Sweden in the Indiana University College of Arts and Sciences, ... and formally naming a new class of fungi that previously ... ,Structures on Roots The new fungal ... 1 (SCG1), has now been found in more than 50 ...
... Brain Institute (HBI) at the University of Calgary,s Faculty ... increases food drive in rats. This new discovery, published ... important insight into why stress is thought to be ... the brain produces neurotransmitters (chemicals responsible for how cells ...
... the Smithsonian Conservation Biology Institute have discovered why older ... this information to introduce vital new genes into the ... and the uteri of 34 cheetahs at eight institutions, ... cheetahs older than 8 years appear normal, the animals, ...
Cached Biology News:Visiting researcher at IU leads international team in formal identification of new fungi class 2Visiting researcher at IU leads international team in formal identification of new fungi class 3Scientists highlight link between stress and appetite 2New discovery positions Smithsonian to bolster genetic diversity among cheetahs 2
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
... Invitrogens EvoQuest Services are ... prevail in the current competitive ... proprietary techniques to express, purify, ... your needs: Structure/Function Studies, Activity ...
albumin from bovine serum (BSA), fluorescein conjugate...
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
Biology Products: